Artículos del autor

solaci

Peripheral vascular disease

Patients with Resistant Hypertension: Nearly 50% doesn’t take medication

The DENERHTN trial (Renal Denervation for Hypertension) confirmed the efficacy of renal denervation in addition to antihypertensive...
solaci -
Heart of SOLACI

Martínez Ríos: “SOLACI Went from a Dream to a World-Renowned Society”

Dr. Marco Antonio Martínez Ríos comes from a family of physicians. “Studying Medicine was the most natural thing...
solaci -
Live Cases and Live in a Box Cases

SYNTAX I, SYNTAX II and SYNTAX III: From invasive to non-invasive assessment of Coronary Stenosis

Exhibitor: Patrick W. Serruys Recorded by TV Med – June 8th, 2016 / SOLACI-SBHCI Congress 2016.   We value your...
solaci -
Carotid

Carotid PCI at Long Term: Effective in Stroke Prevention?

There are no data outside controlled studies, neither are there long term outcomes, on carotid artery stenting....
solaci -
Acute coronary syndromes

Are Pharmacoinvasive Strategy and Primary PCI Comparable?

The Strategic Reperfusion Early After Myocardial Infarction trial and the French Registry of Acute Myocardial Infarction 2015 suggest that...
solaci -
Antiplatelet

Prasugrel vs. Ticagrelor in Diabetics with Heart Disease

Diabetic patients are increased risk of thrombotic events, which is why an effective antiplatelet therapy is crucial...
solaci -
Antiplatelet

Procedural Complexity Affects Decision-Making Regarding DAPT Duration

Much of the speculation around the way of individualizing dual antiplatelet therapy (DAPT) duration after coronary angioplasty...
solaci -
Acute coronary syndromes

Deferring Lesions by FFR in ACS: Yes or No?

Deferring treatment through angioplasty in non-ischemic lesions by fractional flow reserve (FFR) is associated with excellent long-term...
solaci -